Golimumab Subcutaneous and Lithium Carbonate Tablets
Determining the interaction of Golimumab Subcutaneous and Lithium Carbonate Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: golimumab
Brand name: Simponi, Simponi SmartJect, Simponi Aria
Synonyms: Golimumab
Generic Name: lithium
Brand name: Lithobid, Eskalith, Lithonate, Lithotabs, Eskalith-CR
Synonyms: Lithium
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Golimumab Subcutaneous-Lithium Citrate Syrup
- Golimumab Subcutaneous-Lithium Controlled-Release and Extended-Release Tablets
- Golimumab Subcutaneous-Lithium ER
- Golimumab Subcutaneous-Lithium Oral Solution
- Golimumab Subcutaneous-Lithium Salts
- Golimumab Subcutaneous-Lithium Syrup and Oral Solution
- Lithium Carbonate Tablets-GoLYTELY
- Lithium Carbonate Tablets-Gonadorelin
- Lithium Carbonate Tablets-Gonadorelin Intravenous, Injection
- Lithium Carbonate Tablets-Gonadotropin, Chorionic
- Lithium Carbonate Tablets-Gonal-F
- Lithium Carbonate Tablets-Gonal-f RFF